Antibody-Drug Conjugate Pipeline Review by Target, Drug, Phase and Company; New Report Launched
The competitive intelligence report "Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company" evaluates and describes the competitive landscape of antibody-drug conjugates (ADCs) in a tabular format by target, payload, R&D phase and company as of December 2016.
View full press release